New Findings On Receptor Regulation May Lead To Better Drugs For Diabetes

Promising new treatments for adult-onset diabetes hinge on the action of a single protein: a receptor that controls how cells respond to the hormone insulin.

By binding to the receptor, drugs known as thiazolidinediones (TZDs, for short) raise the body's sensitivity to insulin, allowing it to better regulate its blood sugar levels. Researchers at the University of Pennsylvania Medical Center have now revealed a key step in the regulation of this receptor -- information which could lead to safer and more effective medicines for diabetes. The group's findings appear in the November 26 issue of Nature.

The receptor, called PPAR-gamma, resembles several other receptor proteins that bind to small hormones. In fat cells, this receptor influences a variety of processes, including sugar metabolism and fat cell proliferation, by turning specific genes on and off. Chemicals that can bind to the receptor increase insulin's ability to lower blood sugar in the body.

That action is crucial to controlling adult-onset diabetes, which results not from a lack of insulin, but from the inability of cells to heed insulin's signals, says senior author Mitchell A. Lazar, MD, PhD, professor of medicine and genetics at Penn. More than 15 million Americans are thought to suffer from adult-onset diabetes, which typically develops after age 40. Half are unaware they have the disease, which is also a risk factor for heart disease and stroke.

"The reason this new family of drugs works to control adult-onset diabetes is because they bind to the receptor we worked with," says Lazar, who is also director of Penn's Diabetes Center. Rezulin, manufactured by Parke-Davis, is the only TZD currently on the market; several TZD compounds are in clinical trials and others are at earlier stages of development.

Unfortunately, as Lazar and coworkers discovered in 1996, when TZD activates PPAR-gamma, fat cells not only respond more readil

Contact: Franklin Hoke or Rebecca Harmon
University of Pennsylvania School of Medicine

Page: 1 2 3

Related biology news :

1. Findings suggest need for new view of p53 cancer proteins interaction with DNA
2. Findings redefine mechanism of action of RNA helicase enzymes
3. Findings of novel nanoproperties in selenium produced by bacteria open new area of exploration
4. Findings could aid efforts to harness nature for making drugs
5. Findings offer clue to how molecule can both stimulate, suppress cell growth
6. Findings offer further understanding about growth and development in young male gymnasts
7. Findings in frog oocytes may help study of chromosome physiology
8. Findings aid understanding of neurodegenerative diseases
9. Findings show exceptional longevity runs in families
10. Findings give insight into how colon cells transform into precancerous polyps
11. Findings conclude sustained caffeine intake negates the benefits of creatine supplements

Post Your Comments:

(Date:7/18/2020)... ... 17, 2020 , ... Commercial launch readiness is a critical stage in a ... cure or vaccine, the global economic downturn will only increase price pressures overall for ... and capturing full value from every product launch is critical. However, history shows that ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. ... Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at ... Paul J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label ...
(Date:6/28/2020)... Switzerland (PRWEB) , ... June ... ... provider of enterprise software solutions for biopharmaceutical R&D, today announced that it ... company developing innovative, full-length multispecific antibodies (Multiclonics®), to support their translational and ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... Diversified ... systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. , ... one or two switches in a push-pull configuration; yielding fast fall time for ...
(Date:7/31/2020)... ... 2020 , ... The SDX® Respiratory Gating System , ... reached its 20th anniversary of worldwide use. Introduced in the US over the ... University of Pennsylvania, University of Michigan, University of Maryland, University of California San ...
(Date:7/18/2020)... ... ... “We are thrilled to deliver this new technology to the industry” said Matt Hundt, ... market and we were pleased that the IFT jury recognized that.” reFRESH™ couples the ... natural way to extend the shelf life and improve the safety of perishable foods ...
(Date:7/10/2020)... ... July 09, 2020 , ... PathSensors ... (MIT) has expanded the company’s exclusive license to include clinical applications for ... diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast and ...
Breaking Biology Technology:
Cached News: